XML 38 R27.htm IDEA: XBRL DOCUMENT v3.25.1

Segments (Tables)

3 Months Ended

Mar. 31, 2025

Segments [Abstract]

Segment Data

								Reportable						Chemed
		VITAS			Roto-Rooter			Segments			Corporate			Consolidated
Service revenues and sales		$	407,400		$	239,543		$	646,943		$	-		$	646,943
Cost of services provided and goods sold
(excluding depreciation)
Wages			235,173			77,471			312,644			-			312,644
Patient care expense			40,379			-			40,379			-			40,379
Other expenses			37,255			40,252			77,507			-			77,507
Total cost of services provided and goods sold			312,807			117,723			430,530			-			430,530
Selling, general and administrative expense
Wages			17,527			21,187			38,714			4,731			43,445
Advertising			-			18,169			18,169			-			18,169
Stock compensation			-			-			-			11,748			11,748
Other expenses			9,011			23,293			32,304			(79)			32,225
Total selling, general and administrative expense			26,538			62,649			89,187			16,400			105,587
Depreciation			5,196			8,237			13,433			12			13,445
Amortization			26			2,546			2,572			-			2,572
Other operating expense/(income)			64			(13)			51			-			51
Total costs and expenses			344,631			191,142			535,773			16,412			552,185
Income/(loss) from operations			62,769			48,401			111,170			(16,412)			94,758
Interest expense			(48)			(132)			(180)			(149)			(329)
Intercompany interest income/(expense)			5,296			3,930			9,226			(9,226)			-
Other income - net			48			10			58			1,187			1,245
Income/(expense) before income taxes			68,065			52,209			120,274			(24,600)			95,674
Income taxes			(18,035)			(12,265)			(30,300)			6,383			(23,917)
Net income/(loss)		$	50,030		$	39,944		$	89,974		$	(18,217)		$	71,757
Identifiable assets		$	886,705		$	535,733		$	1,422,438		$	304,077		$	1,726,515
Additions to long-lived assets		$	9,476		$	4,289		$	13,765		$	-		$	13,765

‎

Segment data for the three months ending March 31, 2024 are as follows (in thousands):

								Reportable						Chemed
		VITAS			Roto-Rooter			Segments			Corporate			Consolidated
Service revenues and sales		$	354,007		$	235,226		$	589,233		$	-		$	589,233
Cost of services provided and goods sold
(excluding depreciation)
Wages			203,424			78,534			281,958			-			281,958
Patient care expense			35,074			-			35,074			-			35,074
Other expenses			33,398			34,697			68,095			-			68,095
Total cost of services provided and good sold			271,896			113,231			385,127			-			385,127
Selling, general and administrative expense
Wages			16,529			21,075			37,604			3,940			41,544
Advertising			-			19,524			19,524			-			19,524
Stock compensation			-			-			-			18,147			18,147
Other expenses			7,263			20,661			27,924			8,734			36,658
Total selling, general and administrative expense			23,792			61,260			85,052			30,821			115,873
Depreciation			5,166			8,108			13,274			13			13,287
Amortization			26			2,495			2,521			-			2,521
Other operating expense			7			85			92			-			92
Total costs and expenses			300,887			185,179			486,066			30,834			516,900
Income/(loss) from operations			53,120			50,047			103,167			(30,834)			72,333
Interest expense			(46)			(117)			(163)			(262)			(425)
Intercompany interest income/(expense)			5,194			3,442			8,636			(8,636)			-
Other income - net			29			22			51			12,526			12,577
Income/(expense) before income taxes			58,297			53,394			111,691			(27,206)			84,485
Income taxes			(14,327)			(12,541)			(26,868)			7,400			(19,468)
Net income/(loss)		$	43,970		$	40,853		$	84,823		$	(19,806)		$	65,017
Identifiable assets		$	772,631		$	524,223		$	1,296,854		$	430,779		$	1,727,633
Additions to long-lived assets		$	13,470		$	5,855		$	19,325		$	7		$	19,332

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-25

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration